Psychedelics medicine company MindMed recently made its Nasdaq debut, making it only the second company of its kind to list on the exchange. The company has a current market cap of $1.3 billion and is working on clinical trials to explore the medicinal properties of powerful psychedelics. Our Daniela Cambone speaks with CEO and co-founder JR Rahn about how MindMed is shaking things up on Wall Street. Video by Stansberry Research.
Bybit Bonus Bash
>> New users can receive up to $1000 Bonus upon deposit + $10 Coupon regardless the deposit amount.
More information : Read here >>
